From Yahoo Finance: 2025-06-08 18:50:00

Hims & Hers stock is rising due to a weight-loss drug partnership, expanding into Europe, offering personalized drugs, and soaring share prices. The company aims for $6.5 billion in revenue by 2030, with a focus on direct sales, avoiding insurance markets, and providing affordable medications. Partnerships, acquisitions, and growth strategies drive potential for long-term investors.



Read more at Yahoo Finance: Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?